πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 180 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7659278

Use of low molecular weight compounds for preparing a medicament useful in treating mutant

APREA AB Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7626042

O-substituted hydroxyaryl derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7611885

Pharmaceutically compatible method for purifying intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608422

Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhib

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598418

Amide derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547716

Sulfonamide derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7411076

Coumarin derivative

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7396816

Low-molecular weight peptides inhibiting ion channel activity

Pharmadesign, Inc. Β· Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7346387

Methods for improved selectivity in photo-activation and detection of molecular diagnostic

Provectus Devicetech, Inc. Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332590

Molecular characteristics of non-small cell lung cancer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183389

Monoclonal antibodies and cell surface antigens for the detection and treatment of small c

Molecular Discoveries, Inc. Β· Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119103

Ξ²3-Adrenoreceptor agonists, agonist compositions and methods of using

Molecular Design International, Inc. Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6986891

Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses t

Molecular Discoveries, L.L.C. Β· Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6919357

Ξ± adrenergic agents

Molecular Design International, Inc. Β· Granted Tue Jul 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6869959

Heterocyclic carboxylic acid derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6838574

Dicarba-closo-dodecarborane derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6825213

&bgr;3-adrenoreceptor agonists, agonist compositions and methods of using

Molecular Design International, Inc. Β· Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6774180

Synthesis of high molecular weight non-peptidic polymer derivatives

Nektar Therapeutics AL, Corporation Β· Granted Tue Aug 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6656706

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6617134

Dimer of molecular variant of apolipoprotein and processes for the production thereof

Esperion Therapeutics, Inc. Β· Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6610334

Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for impro

The Regents of the University of California Β· Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6600021

Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for impro

The Regents of the University of California Β· Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583271

Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for impro

The Regents of the University of California Β· Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6476017

Compounds activating pharmacological effect of retinoids

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired